We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Efforts to Integrate Clinical Trials Data into EHRs

By HospiMedica International staff writers
Posted on 21 Mar 2012
Print article
The US National Cancer Institute (NCI, Bethesda, MD, USA) is joining forces with Health Level Seven International (HL7, Ann Arbor, MI, USA) to connect trials data with electronic health records (EHRs), the group announced last month.

Talk of standards to make EHR systems interoperable with electronic data capture (EDC)-type data has taken place for several years, with little to show in the way of progress. But HL7 said that it plans to launch a pilot project in late 2012, with the ultimate goal of applying the same standards the group uses for packaging clinical care data to clinical trials data, which could then be used by doctors to assist in and tailor treatments for patients who have been involved in clinical research.

In general, pharmaceutical companies have applauded efforts to open pipelines between clinical trials systems and EHRs, which could provide them with a way to find patients that fit their drug trials electronically. Aiming to stay on the leading edge, Oracle (Redwood Shores, CA, USA) launched a health research platform that offers the ability to analyze clinical trials data alongside EHR data. The company is also providing the same technology for a pilot electronic research network progressing in New York State (USA) as part of the Partnerships to Advance Clinical Electronic Research (PACeR).

PACeR and other efforts have attracted government agencies, hospitals, pharmaceutical corporations, academic groups and tech providers to the table, as these parties all have a stake in speeding up the notoriously slow process of bringing new therapies to market. With patient and clinical trials data in electronic format and interoperable among different systems, the NCI and HL7 believe they can contribute to the goal.

HL7 is a non-profit standards development organization with affiliates established in more than 30 countries dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery, and evaluation of health services. HL7 has more than 2,300 members, representing approximately 500 corporate members, which include more than 90% of the information systems vendors serving healthcare.

Related Links:

US National Cancer Institute
Health Level Seven International
Oracle


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Mammography Analytics Platform
Unifi Analytics Software
New
Tabletop Steam Autoclave
T24

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.